Investigative Ophthalmology & Visual Science Cover Image for Volume 65, Issue 7
June 2024
Volume 65, Issue 7
Open Access
ARVO Annual Meeting Abstract  |   June 2024
Impact of Deep Capillary Plexus Non-perfusion on Visual Acuity in Diabetic Retinopathy through OCTA Analysis
Author Affiliations & Notes
  • Daniela Castellanos Canales
    Ophthalmology, Northwestern University Feinberg School of Medicine, Chicago, Illinois, United States
  • Nicole Decker
    Ophthalmology, Northwestern University Feinberg School of Medicine, Chicago, Illinois, United States
  • Brandon Vo Duffy
    Ophthalmology, Northwestern University Feinberg School of Medicine, Chicago, Illinois, United States
  • Taffeta Chingning Yamaguchi
    Boehringer Ingelheim International GmbH, Ingelheim, Rheinland-Pfalz, Germany
  • Liz Pearce
    Boehringer Ingelheim International GmbH, Ingelheim, Rheinland-Pfalz, Germany
  • Amani A Fawzi
    Ophthalmology, Northwestern University Feinberg School of Medicine, Chicago, Illinois, United States
  • Footnotes
    Commercial Relationships   Daniela Castellanos Canales None; Nicole Decker None; Brandon Duffy None; Taffeta Chingning Yamaguchi Boehringer-Ingelheim International, Code E (Employment); Liz Pearce Boehringer-Ingelheim International, Code E (Employment); Amani Fawzi Regeneron, Code C (Consultant/Contractor), Roche/Genentech, Code C (Consultant/Contractor), Boehringer-Ingelheim, Code C (Consultant/Contractor), Regen Xbio, Code C (Consultant/Contractor), 3Helix, Code C (Consultant/Contractor), Boehringer-Ingelheim, Code F (Financial Support)
  • Footnotes
    Support  NRSA Grant 5T32DK007169, NIH Grant R01EY31815, Boehringer Ingelheim.
Investigative Ophthalmology & Visual Science June 2024, Vol.65, 1752. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Daniela Castellanos Canales, Nicole Decker, Brandon Vo Duffy, Taffeta Chingning Yamaguchi, Liz Pearce, Amani A Fawzi; Impact of Deep Capillary Plexus Non-perfusion on Visual Acuity in Diabetic Retinopathy through OCTA Analysis. Invest. Ophthalmol. Vis. Sci. 2024;65(7):1752.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose : Considering its proximity and importance to the photoreceptors, we evaluated the influence of deep capillary plexus (DCP) non-perfusion on visual acuity (VA) in eyes with diabetic retinopathy (DR).

Methods : Our study included 313 eyes with DR severity ranging from no retinopathy (DMnoDR) to proliferative DR (PDR). 3x3 OCTA scans of the DCP were averaged to measure vessel density (VD), vessel length density (VLD), and geometric perfusion deficit (GPD). Best corrected VA (BCVA) and low-luminance VA (LLVA) were measured per the Early Treatment Diabetic Retinopathy Study (ETDRS) protocol. LLVA deficit (LLVAD) was considered as the difference between BCVA and LLVA. The relationship between OCTA metrics and VA was evaluated using a partial spearman correlation for nonparametric variables, correcting for confounding factors (age, HbA1c, OCTA quality, hypertension and lens status).

Results : We found moderate linear relationships between BCVA on one side and DCP-VD (r=.269, p<0.001) and DCP-VLD (r=.356, p<0.001) on the other. A moderate negative linear relationship was seen between BCVA and DCP-GPD (r=-.357, p<0.001). We also found moderate linear relationships between LLVA on one side and DCP-VD (r=.335, p<0.001) and DCP-VLD (r=.441, p<0.001) on the other. Also, we saw a moderate negative linear relationship between LLVA and DCP-GPD (r=-.414, p<0.001). LLVAD showed no significant correlation to non-perfusion OCTA metrics (p >.05).

Conclusions : Perfusion deficits in the DCP correlate moderately to vision loss, suggesting that this capillary layer may contribute to normal visual function.

This abstract was presented at the 2024 ARVO Annual Meeting, held in Seattle, WA, May 5-9, 2024.

 

Figure 1. Vessel density (VD), vessel length density (VLD) and geometric perfusion deficit (GPD) using optical coherence tomography (OCTA). A, B, C, D measurements from an eye with non-proliferative diabetic retinopathy and good visual acuity. E, F, G, H measurements from a proliferative diabetic retinopathy case with poor visual acuity. *BCVA, best corrected visual acuity;* LLVA, low luminance visual acuity.

Figure 1. Vessel density (VD), vessel length density (VLD) and geometric perfusion deficit (GPD) using optical coherence tomography (OCTA). A, B, C, D measurements from an eye with non-proliferative diabetic retinopathy and good visual acuity. E, F, G, H measurements from a proliferative diabetic retinopathy case with poor visual acuity. *BCVA, best corrected visual acuity;* LLVA, low luminance visual acuity.

 

Definitions:DM, diabetes mellitus; BCVA, best corrected visual acuity ;LLVA, low luminance visual acuity; VD, vessel density; VLD, vessel length density; GPD, geometric perfusion peficit; DM no DR, diabetes without diabetic retinopathy; NPDR, non-proliferative diabetic retinopathy; PDR, treatment naïve and quiescent proliferative diabetic retinopathy; OCTA, optic coherence tomography angiography.

Definitions:DM, diabetes mellitus; BCVA, best corrected visual acuity ;LLVA, low luminance visual acuity; VD, vessel density; VLD, vessel length density; GPD, geometric perfusion peficit; DM no DR, diabetes without diabetic retinopathy; NPDR, non-proliferative diabetic retinopathy; PDR, treatment naïve and quiescent proliferative diabetic retinopathy; OCTA, optic coherence tomography angiography.

×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×